Mitsubishi Heavy Industries (MHI) is to begin full-scale production of an image-guided radiotherapy machine, the TM2000, capable of delivering stereotactic and intensity-modulated treatments fast. Radiotherapy — high-energy radiation from X-rays used to shrink tumours and kill cancer cells — is effective but often impacts tissue surrounding the area being treated. Similarly, conventional radiotherapy machines are said to require significant time for accurate irradiation positioning to the tumour tissue, which is inconvenient to both the patient and hospital staff.
展开▼
